Malaria parasites camouflage themselves from the immune defenses of expectant mothers

Collaborative research between Liverpool School of Tropical Medicine and the University of Copenhagen, published last week in the Proceedings of the National Academy of Sciences, have answered a long standing mystery, why and how malaria parasites go unnoticed by the immune defences of pregnant mothers. Maternal malaria kills 10,000 women and between 10,000 to 200,000 babies every year. Malaria is a preventable and treatable disease and every life lost is needless.

The malaria parasites take on a camouflage that enables their presence to go undetected in the placenta, and therefore they are not attacked by the immune system. Ironically, the camouflage adopted is itself an antibody, although a giant example called IgM that is very different to the IgG antibodies commonly used to attack the parasite.

The findings are fundamental to understanding immunity to this dangerous form of the disease and to developing a vaccine to protect pregnant women.

Provided by Liverpool School of Tropical Medicine

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Profiling malaria-causing parasites

Feb 07, 2011

The majority of fatal cases of malaria are caused by infection with the parasite Plasmodium falciparum. Most at risk are young children and women who are pregnant. A team of researchers, led by Patrick Duffy, at the Nation ...

Recommended for you

Proper stem cell function requires hydrogen sulfide

2 hours ago

Stem cells in bone marrow need to produce hydrogen sulfide in order to properly multiply and form bone tissue, according to a new study from the Center for Craniofacial Molecular Biology at the Herman Ostrow School of Dentistry ...

Bionic ankle 'emulates nature'

7 hours ago

These days, Hugh Herr, an associate professor of media arts and sciences at MIT, gets about 100 emails daily from people across the world interested in his bionic limbs.

Firm targets 3D printing synthetic tissues, organs

8 hours ago

(Medical Xpress)—A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term the company ...

User comments